Log In
BCIQ
Print this Print this
 

clonidine topical gel (formerly ARC-4558)

Also known as: clonidine

  Manage Alerts
Collapse Summary General Information
Company Arcion Therapeutics Inc.
DescriptionTopical 0.1% gel formulation of clonidine, an imidazoline derivative and an adrenergic receptor alpha 2 (ADRA2) agonist
Molecular Target Adrenergic receptor alpha 2 (ADRA2)
Mechanism of ActionAdrenergic receptor alpha 2 (ADRA2) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetic neuropathy
Indication DetailsTreat painful diabetic neuropathy
Regulatory Designation U.S. - Fast Track (Treat painful diabetic neuropathy)
PartnerBioDelivery Sciences International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/10/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today